Erin Henry Net Worth

The estimated Net Worth of Erin Henry is at least $157 Tausend dollars as of 3 February 2020. Ms Henry owns over 167 units of Conformis stock worth over $152,559 and over the last 5 years she sold CFMS stock worth over $4,717.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms Henry CFMS stock SEC Form 4 insiders trading

Ms has made over 2 trades of the Conformis stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 167 units of CFMS stock worth $167 on 3 February 2020.

The largest trade she's ever made was selling 3,204 units of Conformis stock on 3 January 2020 worth over $4,550. On average, Ms trades about 1,124 units every 10 days since 2019. As of 3 February 2020 she still owns at least 67,504 units of Conformis stock.

You can see the complete history of Ms Henry stock trades at the bottom of the page.

Ms. Erin Henry biography

Erin Henry is the Corp. Controller at Conformis.

How old is Ms Henry?

Ms Henry is 36, she's been the Corp. Controller of Conformis since . There are 14 older and no younger executives at Conformis. The oldest executive at Conformis Inc. is Kenneth Fallon, 80, who is the Independent Chairman of the Board.

What's Ms Henry's mailing address?

Erin's mailing address filed with the SEC is C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.

Insiders trading at Conformis

Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang und Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.

What does Conformis do?

our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h

Complete history of Ms Henry stock trades at Conformis

Conformis executives and stock owners

Conformis executives and other stock owners filed with the SEC include:

• Mark Augusti,
  President, Chief Executive Officer, Director
• Mark A. Augusti,
  CEO, Pres & Director
• Robert S Howe,
  CFO & Treasurer
• J. Brent Alldredge J.D.,
  Corp. Sec.
• J. Brent Alldredge,
  Chief Legal Officer and Corporate Secretary
• Michael Milligan,
  Independent Director
• Richard Meelia,
  Independent Director
• Bradley Langdale,
  Independent Director
• Philip Johnston,
  Independent Director
• Carrie Bienkowski,
  Director
• Gary Maingot,
  Senior Vice President - Operations
• Robert Howe,
  Chief Financial Officer, Treasurer
• Kenneth Fallon,
  Independent Chairman of the Board
• Denise E. Pedulla J.D., M.P.H.,
  Chief Legal Officer & Corp. Sec.
• Michael Fillion,
  Chief Operating Officer
• Erin Henry,
  Corp. Controller
• Terrance Wong,
  Sr. VP of HIP & Private Label Engineering
• Eric Rickenbach,
  Sr. VP of US Sales
• Allison Baker,
  Director of HR
• Farzin Khaghani,
  VP of U.S. Marketing
• John Slamin,
  Chief Technology Officer
• Daniel Steines,
  Chief Technology Officer
• Robert Iii Law,
  Senior Vice President, Sales
• Philipp Lang,
  President & C.E.O.
• Paul S Weiner,
  Chief Financial Officer
• David Cerveny,
  Chief Legal Off & G. Counsel
• Denise E Pedulla,
  FORMER CLO & SECRETARY
• Erin Henry,
  CORP CONTROLLER & INTERIM PAO
• Christine Desrochers,
  Fmr Interim CFO & Controller
• Capital Management Llcchris...,
  
• Patricia A Davis,
  CLO & GENERAL COUNSEL
• Dhabi Investment Authority ...,
  
• Frank Muhlenbeck,
  Director
• Laurent Souviron,
  Director
• Gary P Fischetti,